Jacobs Levy Equity Management, Inc Horizon Therapeutics Public LTD CO Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$71.83 - $95.48 $5.9 Million - $7.84 Million
-82,139 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$67.0 - $84.39 $4.62 Million - $5.82 Million
69,022 Added 526.2%
82,139 $6.01 Million
Q3 2020

Nov 16, 2020
BUY
$55.23 - $79.93 $724,451 - $1.05 Million
13,117 New
13,117 $1.02 Million
Q3 2019

Nov 14, 2019
SELL
$23.0 - $27.97 $430,100 - $523,039
-18,700 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$22.81 - $28.48 $426,547 - $532,576
18,700 New
18,700 $450,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email